Tempus AI(TEM.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Tempus AI
TEM.US
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies.
758.15 B
TEM.USMarket value -Rank by Market Cap -/-

Financial Score

01/02/2026 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking22/62
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-72.61%E
    • Profit Margin-18.45%D
    • Gross Margin62.82%A
  • Growth ScoreA
    • Revenue YoY72.58%A
    • Net Profit YoY74.54%A
    • Total Assets YoY134.78%A
    • Net Assets YoY845.18%A
  • Cash ScoreC
    • Cash Flow Margin-542.12%E
    • OCF YoY72.58%A
  • Operating ScoreB
    • Turnover0.68B
  • Debt ScoreE
    • Gearing Ratio77.74%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 166,250 Shares of Stock

    Tempus AI CEO Eric Lefkofsky sold 166,250 shares at $65.56 each, totaling $10.9 million, reducing his ownership by 1.83% to 8,941,533 shares valued at approximately $586.2 million. The stock traded down 5.8% to $59.82, with a market cap of $10.64 billion. Analysts have mixed ratings on the stock, with a consensus target price of $87.20. Recent earnings showed a revenue increase of 84.7% year-over-year, with an EPS of -$0.11, surpassing estimates. Institutional investors have been active in buying and selling shares of Tempus AI.

    Market Beat·
    US
    IDNA
    -1.99%
    US
    PBE
    -0.74%
    US
    SBIO
    -2.12%
    Market Beat·
    US
    IDNA
    -1.99%
    US
    PBE
    -0.74%
    US
    SBIO
    -2.12%

    Promising Artificial Intelligence Stocks To Watch Today - January 30th

    BigBear.ai, Hut 8, Fluence Energy, Tempus AI, and SoundHound AI are highlighted as promising Artificial Intelligence stocks to watch today, according to MarketBeat. These companies are involved in various AI applications, from decision intelligence to energy storage and healthcare solutions. Investors are drawn to these stocks for potential growth driven by AI adoption, though risks include technological changes and regulatory uncertainties. The stocks have shown high trading volumes recently, indicating investor interest.

    Market Beat·
    US
    HUT
    -9.26%
    US
    ROBT
    -2.57%
    US
    BBAI
    -8.70%
    Market Beat·
    US
    HUT
    -9.26%
    US
    ROBT
    -2.57%
    US
    BBAI
    -8.70%

    Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares

    Eric P. Lefkofsky, CEO of Tempus AI Inc., reported the sale of Class A common shares of the company. The full filing is available through the provided link. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice. The original content was published via EDGAR by Tempus AI Inc. on January 30, 2026.

    Reuters·
    US
    ARKG
    -2.93%
    US
    SBIO
    -2.12%
    US
    TEM
    -5.81%
    Reuters·
    US
    ARKG
    -2.93%
    US
    SBIO
    -2.12%
    US
    TEM
    -5.81%

    Tempus AI has been on a consecutive decline for several days; can the bottom divergence ferment a rebound from the oversold condition?

    Tempus AI (TEM.US) stock price has recently declined for several consecutive days, with a clear death cross signal, and market sentiment is extremely cautious. Amid continuous downward trends, capital outflows are frequent, but it can be seen in intraday trading that a few sharp funds have begun to position themselves for a rebound expected from the bottom divergence signal. Community traders are focused on the hot topic of "what price is the true bottom," with short-term bulls ready to act but hesitant to make moves. The overall sector trend is weak with no obvious windfall, and there are no substantial catalysts from the company itself. If the technical trend shows a golden needle/long lower shadow or extreme volume support during the day, a rapid short-term recovery may be expected. The strategy suggests closely monitoring the direction of main funds and the intraday volume-price coordination, with quick entry and exit being key. Preventing the main force from inducing a failed rally and exacerbating losses is crucial; only when the bottom support is truly confirmed as solid and large orders from the main force return can the market be considered reliable. Do not chase the top, do not avoid the last stick; those who aim to seize the rebound at key points must have a "quick to act" mindset

    Technical Forecast·
    US
    TEM
    -5.81%
    Technical Forecast·
    US
    TEM
    -5.81%

    Tempus AI stabilizing unsuccessful, is a violent rebound from overselling coming?

    Tempus AI (TEM.US) has been declining for several consecutive days, with increased active selling after failing to break through its high point, leading to a short-term cooling of sentiment in the AI healthcare sector. Community opinions are nearly unanimous: if there are favorable stimuli or policy catalysts in the future, it is easy to replicate the sharp rebound trend of previously hot stocks. Current trading volume has moderately increased, and the technical pattern is approaching previous low levels, making intraday sudden buying or unusual capital movements worthy of close attention. Community traders are actively discussing whether the next step will be further declines or a brewing sharp rebound from oversold conditions, with the FOMO atmosphere gradually intensifying. It is anticipated that once the key support line stops falling and capital flows in, a violent V-shaped rebound may be imminent. However, caution is advised as new lows could lead to rapid risk release; it is recommended to pay attention to real-time market conditions and industry news, with a focus on tracking the dynamics of major players

    Technical Forecast·
    US
    IBB
    -1.04%
    US
    FBT
    -1.88%
    US
    PBE
    -0.74%
    Technical Forecast·
    US
    IBB
    -1.04%
    US
    FBT
    -1.88%
    US
    PBE
    -0.74%
    Posts
    View More

    $SIA(C6L.SG)represents a stable holding opportunity with modest upside potential. It offers defensive characteristics with strong government backing (Temasek holds 50.49%), consistent dividend yield o...

    NANCY PELOSI'S LATEST FINANCIAL DISCLOSURE WAS RELEASED TODAY.

    She bought shares via exercising deep ITM call options on:

    $Alphabet(GOOGL.US) 5000 shares

    $Amazon(AMZN.US) 5000 shares

    $NVIDIA(NVDA.US) 5..................
    • 0

    No green to red stops hit while I was away from the screens. Never leave your wing man. I put hard stops in the machine. $Chewy(CHWY.US) $Palo Alto Networks(PANW.US) $Tempus AI(TEM.US) $Qualcomm(QCO......

    $Tempus AI(TEM.US) a filled black stick and back under 50ma on the daily not the best end of the day to a great move at the open. Stops in the machine to make a variety of profit

    Source: Sunrise Trader...

    $Tempus AI(TEM.US) giving us the move if long

    Source: Sunrise Trader

    © 2026 Longbridge｜Disclaimer